Thursday, March 28, 2024

GET OUR FREE E-NEWSLETTER

“You may choose to look the other way, but you can never say again that you did not know.”

— William Wilberforce

Search

FDA Panel Endorses New Alzheimer’s Drug After Accelerated Approval

elderly man

The newest Alzheimer’s drug is on its way for full regulatory approval after a U.S. Food and Drug Administration (FDA) advisory panel voted that the drug was beneficial in slowing cognitive decline. The drug is expected to be fully approved by July 6, 2023.1 In clinical trials the drug, known as lecanemab, demonstrated a 27 […]

FDA Criticized for Working Too Closely With Biotech Company to Approve Alzheimer’s Drug

FDA Criticized for Working Too Closely With Biotech Company to Approve Alzheimer’s Drug

New findings from a congressional investigation into the Food and Drug Administration and the biotech company Biogen find that the FDA broke its own protocols to approve a new Alzheimer’s drug last year. The findings conclude that the regulator worked too closely with Biogen, despite significant concerns over the limited and side effects of the […]

Research Linked to Leading Cause of Alzheimer’s Disease May Have Been Fabricated

holding brain

For nearly two decades, Alzheimer’s disease research, research funding, and prescribed drugs have been centered around a 2006 research paper hypothesizing that the cognitive decline causing the debilitating disease is due to buildup in the brain of a protein called the amyloid beta (Aβ) protein. But a recent investigation is questioning whether the data in […]

Search in Site

To search in site, type your keyword and hit enter

Search